ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Alan P. Kypson
James D. St. Louis
Shankha S. Biswas
Kevin P. Landolfo
James E. Lowe
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hughes, G. C.
Right arrow Articles by Lowe, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hughes, G. C.
Right arrow Articles by Lowe, J. E.

Ann Thorac Surg 2000;70:504-509
© 2000 The Society of Thoracic Surgeons

Original articles: cardiovascular

Induction of angiogenesis after TMR: a comparison of holmium:YAG, CO2, and excimer lasers

G. Chad Hughes, MDa, Alan P. Kypson, MDa, Brian H. Annex, MDb, Bangliang Yin, MDa, James D. St. Louis, MDa, Shankha S. Biswas, MDa, R. Edward Coleman, MDc, Timothy R. DeGrado, PhDc, Carolyn L. Donovan, MDb, Kevin P. Landolfo, MDa, James E. Lowe, MDa

a Division of Cardiovascular and Thoracic Surgery, Duke University Medical Center, Durham, North Carolina, USA
b Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA
c Department of Radiology, Duke University Medical Center, Durham, North Carolina, USA

Address reprint requests to Dr Lowe, Department of Surgery, Duke University Medical Center, Box 3954, Durham, NC 27710
e-mail: Lowe0004{at}mc.duke.edu

Background. Transmyocardial laser revascularization (TMR) is an emerging treatment for end-stage coronary artery disease. A variety of lasers are currently available to perform the procedure, although their relative efficacy is unknown. The purpose of this study was to compare changes in myocardial blood flow and function 6 months after TMR with holmium:yttrium-aluminum-garnet (holmium:YAG), carbon dioxide (CO2), and xenon chloride excimer lasers in a model of chronic ischemia.

Methods. Miniswine underwent subtotal (90%) left circumflex coronary stenosis. Baseline positron emission tomography and dobutamine stress echocardiography were performed to document hibernating myocardium in the left circumflex coronary artery distribution. Animals were then randomized to sham redo-thoracotomy (n = 5) or TMR using a holmium:YAG (n = 5), CO2 (n = 5) or excimer (n = 5) laser. Six months postoperatively, the positron emission tomography and dobutamine stress echocardiography studies were repeated and the animals sacrificed.

Results. In animals undergoing TMR with holmium:YAG and CO2 lasers, a significant improvement in myocardial blood flow to the lased left circumflex regions was seen. No significant change in myocardial blood flow was seen in sham- or excimer-lased animals. There was a significant improvement in regional stress function of the lased segments 6 months postoperatively in animals undergoing holmium:YAG and CO2 laser TMR that was consistent with a reduction in ischemia. There was no change in wall motion in sham- or excimer-lased animals. Significantly greater neovascularization was observed in the holmium:YAG and CO2 lased regions than with either the sham procedure or excimer TMR.

Conclusions. Transmyocardial laser revascularization with either holmium:YAG or CO2 laser improves myocardial blood flow and contractile reserve in lased regions 6 months postoperatively. These changes were not seen following excimer TMR or sham thoracotomy, suggesting that differences in laser energy or wavelength or both may be important in the induction of angiogenesis.




This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. Atluri, C. M. Panlilio, G. P. Liao, E. E. Suarez, R. C. McCormick, W. Hiesinger, J. E. Cohen, M. J. Smith, A. B. Patel, W. Feng, et al.
Transmyocardial revascularization to enhance myocardial vasculogenesis and hemodynamic function.
J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 283 - 291.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
K. A. Horvath and Y. Zhou
Transmyocardial Laser Revascularization and Extravascular Angiogenetic Techniques to Increase Myocardial Blood Flow
Card. Surg. Adult, January 1, 2008; 3(2008): 733 - 752.
[Full Text]

Home page
 Ann. Thorac. Surg.Home page
S. K. Mouli, J. Fronza, R. Greene, E. S. Robert, and K. A. Horvath
What is the Optimal Channel Density for Transmyocardial Laser Revascularization?
Ann. Thorac. Surg., October 1, 2004; 78(4): 1326 - 1331.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. A. P. van der Sloot, M. Huikeshoven, R. Tukkie, H. J. Verberne, J. van der Meulen, B. L. F. van Eck-Smit, M. J. C. van Gemert, J. G. P. Tijssen, and J. F. Beek
Transmyocardial revascularization using an XeCl excimer laser: Results of a randomized trial
Ann. Thorac. Surg., September 1, 2004; 78(3): 875 - 881.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Galinanes, M. Loubani, P. R. Sensky, A. Hassouna, G. R. Cherryman, J. N. Leverment, and N. J. Samani
Efficacy of transmyocardial laser revascularization and thoracic sympathectomy for the treatment of refractory angina
Ann. Thorac. Surg., July 1, 2004; 78(1): 122 - 128.
[Abstract] [Full Text] [PDF]

Home page
 SEMIN CARDIOTHORAC VASC ANESTHHome page
N. Svorkdal
Treatment of Inoperable Coronary Disease and Refractory Angina: Spinal Stimulators, Epidurals, Gene Therapy, Transmyocardial Laser, and Counterpulsation
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2004; 8(1): 43 - 58.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
G. C. Hughes, S. S. Biswas, B. Yin, R. E. Coleman, T. R. DeGrado, C. K Landolfo, J. E. Lowe, B. H. Annex, and K. P. Landolfo
Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF
Ann. Thorac. Surg., March 1, 2004; 77(3): 812 - 818.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
G. C. Hughes, M. J. Post, M. Simons, and B. H. Annex
Translational Physiology: Porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis
J Appl Physiol, May 1, 2003; 94(5): 1689 - 1701.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Saririan and M. J. Eisenberg
Myocardial laser revascularization for the treatment of end-stage coronary artery disease
J. Am. Coll. Cardiol., January 15, 2003; 41(2): 173 - 183.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
C. A.U. Heilmann, T. Attmann, P. von Samson, H. Gobel, D. Marme, F. Beyersdorf, and G. Lutter
Transmyocardial laser revascularization combined with vascular endothelial growth factor121 (VEGF121) gene therapy for chronic myocardial ischemia - do the effects really add up?
Eur. J. Cardiothorac. Surg., January 1, 2003; 23(1): 74 - 80.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
M. Ruel, R. A. Kelly, and F. W. Sellke
Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy
Card. Surg. Adult, January 1, 2003; 2(2003): 715 - 750.
[Full Text]

Home page
 Eur. J. Cardiothorac. Surg.Home page
G. Lutter, T. Attmann, C. Heilmann, P. von Samson, B. von Specht, and F. Beyersdorf
The combined use of transmyocardial laser revascularization (TMLR) and fibroblastic growth factor (FGF-2) enhances perfusion and regional contractility in chronically ischemic porcine hearts
Eur. J. Cardiothorac. Surg., November 1, 2002; 22(5): 753 - 761.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Huikeshoven, J. F. Beek, J. A.P. van der Sloot, R. Tukkie, J. van der Meulen, and M. J.C. van Gemert
35 years of experimental research in transmyocardial revascularization: what have we learned?
Ann. Thorac. Surg., September 1, 2002; 74(3): 956 - 970.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. C. Hughes, S. S. Biswas, B. Yin, D. V. Baklanov, B. H. Annex, R. E. Coleman, T. R. DeGrado, C. K. Landolfo, K. P. Landolfo, and J. E. Lowe
A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium
J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1220 - 1228.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
K. A. Horvath, N. Belkind, I. Wu, R. Greene, J. Doukas, J. W. Lomasney, D. D. McPherson, and D. A. Fullerton
Functional comparison of transmyocardial revascularization by mechanical and laser means
Ann. Thorac. Surg., December 1, 2001; 72(6): 1997 - 2002.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. H. Hamawy, L. Y. Lee, S. A. Samy, D. R. Polce, M. Szulc, M. Vazquez, and T. K. Rosengart
Transmyocardial laser revascularization dose response: enhanced perfusion in a porcine ischemia model as a function of channel density
Ann. Thorac. Surg., September 1, 2001; 72(3): 817 - 822.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The Society of Thoracic Surgeons.